News Quantified

DERM – journey medical corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

What Makes Journey Medical Corporation (DERM) a Good Investment? [Yahoo! Finance]

Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript [Seeking Alpha]

Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript [Seeking Alpha]

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]

-13.3%

BEAT

-16.6%

BEAT

18.9%

BEAT

Form 10-Q Journey Medical Corp For: Sep 30

Form 8-K Journey Medical Corp For: Nov 12

Form 8-K Journey Medical Corp For: Sep 25

Top News Gainers

10/17 Dermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference 25.8%

12/10 Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 15.2%

5/7 Dermira, Inc. (DERM) CEO Tom Wiggans on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 12.0%

12/12 Dermira Inc (NASDAQ: DERM) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 10.6%

8/7 Q2/2019 6/30/2019 EPS -0.330 ZacksConsensus -0.900 ActVsEst 0.570 - Beat 10.6%

6/6 Form 4 Dermira, Inc. For: Jun 04 Filed by: Cohen David E 7.3%

12/10 Dermira Receives Fast Track Designation from FDA for Lebrikizumab for the Treatment of Atopic Dermatitis 7.2%

6/14 Form 4 Dermira, Inc. For: Jun 12 Filed by: Nunn Jason Raleigh 5.1%

8/17 Dermira Inc (NASDAQ: DERM) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.1%

1/3 Dermira Inc (NASDAQ: DERM) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.1%

Top News Decliners

11/5 Form 10-Q Dermira, Inc. For: Sep 30 -9.1%

11/13 Dermira Elects Halley E. Gilbert to its Board of Directors -6.9%

6/10 Form 8-K Dermira, Inc. For: Jun 04 -6.1%

11/5 Dermira Inc (NASDAQ: DERM) had its "outperform" rating re-affirmed by analysts at Leerink Swann. They now have a $15.00 price target on the stock, down previously from $23.00. -5.6%

5/8 Dermira Inc (NASDAQ: DERM) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.3%

10/12 Dermira Inc (NASDAQ: DERM) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -5.2%

8/7 Form 8-K Dermira, Inc. For: Aug 07 -5.0%

5/14 Dermira Inc (NASDAQ: DERM) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -4.5%

8/9 Dermira Inc (NASDAQ: DERM) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.4%

10/9 Dermira Announces Initiation of Phase 3 Program Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis -4.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day